Access and reimbursement, patient and provider education, core competencies, and survivorship research funding remain critical barriers for primary central nervous system cancer survivorship, a team of National Cancer Institute Comprehensive Oncology Network Evaluating Rare CNS Tumors experts reported in a workshop summary published in Neuro-Oncology Advances.